Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_assertion type Assertion NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_head.
- NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_assertion description "[Results showed that IL-3-activated IL-4-dominant lymphocytes became IFN-?- dominant lymphocytes after combined HSV-sr39tk/GCV therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_provenance.
- NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_assertion evidence source_evidence_literature NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_provenance.
- NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_assertion SIO_000772 23441198 NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_provenance.
- NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_assertion wasDerivedFrom befree-2016 NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_provenance.
- NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_assertion wasGeneratedBy ECO_0000203 NP1056101.RAOwIHyoxlkbLl47UnplZn6FLZsX-WQBwWDsObNMMWx2U130_provenance.